- Home
- HI vs GLPG Comparison
HI vs GLPG Comparison
Compare HI & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HI | GLPG |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | HI | GLPG |
|---|---|---|
| Price | $31.87 | $34.39 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $32.00 | $31.33 |
| AVG Volume (30 Days) | ★ 655.8K | 122.2K |
| Earning Date | 02-04-2026 | 02-11-2026 |
| Dividend Yield | ★ 2.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $2,673,800,000.00 | $336,643,201.00 |
| Revenue This Year | N/A | $1.76 |
| Revenue Next Year | $2.62 | $0.49 |
| P/E Ratio | $52.20 | ★ N/A |
| Revenue Growth | N/A | ★ 10.31 |
| 52 Week Low | $18.36 | $22.36 |
| 52 Week High | $35.59 | $37.78 |
Technical Indicators
Market Signals| Indicator | HI | GLPG |
|---|---|---|
| Relative Strength Index (RSI) | 62.79 | 67.07 |
| Support Level | $31.81 | $32.13 |
| Resistance Level | $31.86 | $34.48 |
| Average True Range (ATR) | 0.06 | 0.82 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 84.37 | 92.61 |
Price Performance
Historical ComparisonAbout HI Hillenbrand Inc
Hillenbrand Inc is a industrial company that provides engineered processing equipment and solutions to customers around the world. The company operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment and also provider of engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.